Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023
Marta Bertran, Brechje de Gier, Tatiana Garcia Vilaplana, Nina M van Sorge, Hester E de Melker, Anneke Steens · 2026
Read Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023 by Marta Bertran, Brechje de Gier, Tatiana Garcia Vilaplana, Nina M van Sorge, Hester E de Melker, Anneke Steens (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13179478.txt.
Description
Marta Bertran and five co-authors grade shot force gainst hard Hib ill in Dutch kids by brand and plan. Their study appeared in twenty twenty-six. Hard Hib rates fell past shots but rose from twenty eleven to twenty twenty-three, in a span of two brand swaps and a dose plan cut. Two hundred fifty cases and near ten times the mates were read from state lists.
Full plan force ran past ninety-five percent for all three brands in kids past a year. Both dose plans tied high. No fall came with time past the shot. The team say brand and plan shifts do not tell the rise; reach is the aim.
Catalog record
| CREATOR | Marta Bertran, Brechje de Gier, Tatiana Garcia Vilaplana, Nina M van Sorge, Hester E de Melker, Anneke Steens |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |